Arid
DOI10.1016/j.jpba.2020.113764
High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry
Tanaka, Ryota; Kai, Makoto; Goto, Koji; Ohchi, Yoshifumi; Yasuda, Norihisa; Tatsuta, Ryosuke; Kitano, Takaaki; Itoh, Hiroki
通讯作者Tanaka, R (corresponding author), Oita Univ Hosp, Dept Clin Pharm, Yufu, Oita, Japan.
来源期刊JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
ISSN0731-7085
EISSN1873-264X
出版年2021
卷号194
英文摘要Several recent studies on pharmacokinetics of linezolid (LZD) and daptomycin (DAP) reported that plasma concentration was linked to efficacy and adverse effects, suggesting the usefulness of therapeutic drug monitoring (TDM). The usefulness of TDM for tedizolid (TZD) has not been reported, but a previous report showed individual differences in area under the curve depending on body weight. In intensive care unit (ICU) patients, pharmacokinetics was reported to fluctuate due to various factors. Here, we developed a high-throughput and wide-range simultaneous quantification method for LZD, DAP and TZD in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry (UPLCMS/MS). Plasma samples were pretreated by solid-phase extraction using Oasis (R) HLB mu Elution Plate. The assay fulfilled the requirements of US Food and Drug Administration and the European Medicines Agency for bioanalytical method validation. The assay for LZD, DAP and TZD showed good linearity over wide ranges of 100-100000, 150-150000 and 5-5000 ng/mL, respectively. Within-batch accuracy and precision as well as batch-to-batch accuracy and precision for all three drugs fulfilled the criteria of the above guidance. Extraction recovery rates were more than 92.2 % for LZD, 44.7 % for DAP, and 84.8 % for TZD. Matrix effect showed no remarkable differences among low, medium and high quality control samples for the three drugs. The maximum and trough concentrations of three patients each who received LZD, DAP or TZD in ICU were measured by the novel UPLC-MS/MS method. In all patients, the measured concentrations were within the ranges of the calibration curves, demonstrating the feasibility of clinical application of the novel method. In conclusion, we have succeeded to develop the first method for simultaneous quantification of plasma concentrations of LZD, DAP and TZD. (C) 2020 Elsevier B.V. All rights reserved.
英文关键词Linezolid Daptomycin Tedizolid Ultra-performance liquid chromatography coupled to tandem mass spectrometry Intensive care unit Therapeutic drug monitoring
类型Article
语种英语
收录类别SCI-E
WOS记录号WOS:000605512600015
WOS关键词SIMULTANEOUS QUANTIFICATION ; CIPROFLOXACIN ; PIPERACILLIN ; INFECTIONS ; MEROPENEM ; CEFEPIME ; EXPOSURE ; DIALYSIS ; BLOOD
WOS类目Chemistry, Analytical ; Pharmacology & Pharmacy
WOS研究方向Chemistry ; Pharmacology & Pharmacy
资源类型期刊论文
条目标识符http://119.78.100.177/qdio/handle/2XILL650/348033
作者单位[Tanaka, Ryota; Kai, Makoto; Tatsuta, Ryosuke; Itoh, Hiroki] Oita Univ Hosp, Dept Clin Pharm, Yufu, Oita, Japan; [Goto, Koji; Ohchi, Yoshifumi; Yasuda, Norihisa; Kitano, Takaaki] Oita Univ Hosp, Dept Anesthesiol & Intens Care, Fac Med, Yufu, Oita, Japan
推荐引用方式
GB/T 7714
Tanaka, Ryota,Kai, Makoto,Goto, Koji,et al. High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry[J],2021,194.
APA Tanaka, Ryota.,Kai, Makoto.,Goto, Koji.,Ohchi, Yoshifumi.,Yasuda, Norihisa.,...&Itoh, Hiroki.(2021).High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry.JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS,194.
MLA Tanaka, Ryota,et al."High-throughput and wide-range simultaneous determination of linezolid, daptomycin and tedizolid in human plasma using ultra-performance liquid chromatography coupled to tandem mass spectrometry".JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS 194(2021).
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Tanaka, Ryota]的文章
[Kai, Makoto]的文章
[Goto, Koji]的文章
百度学术
百度学术中相似的文章
[Tanaka, Ryota]的文章
[Kai, Makoto]的文章
[Goto, Koji]的文章
必应学术
必应学术中相似的文章
[Tanaka, Ryota]的文章
[Kai, Makoto]的文章
[Goto, Koji]的文章
相关权益政策
暂无数据
收藏/分享

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。